20% Prosol 0.98 g (Threonine LIQUID) 0.98 G

20% PROSOL 0.98 G is an intravenous liquid solution containing threonine, a vital amino acid. It is designed to support nutritional needs in medical settings. This product is manufactured by Baxter Corporation in Canada.

Strength

0.98 G

Pack Size

500/1000/2000ML

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

20% PROSOL 0.98 G is primarily used to provide essential amino acids to patients who cannot meet their nutritional needs through oral intake. Threonine, the active ingredient, plays a crucial role in protein synthesis and overall health. This solution is often administered in clinical settings to support patients undergoing certain medical treatments or procedures.

Side Effects

When administered intravenously, 20% PROSOL 0.98 G delivers threonine directly into the bloodstream. This can help maintain adequate levels of this essential amino acid, supporting various bodily functions. Patients may experience improved nutritional status and overall well-being with regular use.

Precautions & Warnings

As with any intravenous solution, 20% PROSOL 0.98 G should be administered under medical supervision. Patients should be monitored for any adverse reactions. It is important to follow proper handling and storage guidelines to ensure the solution remains effective and safe for use.

Avoid Interactions

Threonine, like other amino acids, can interact with certain medications. Patients should inform their healthcare provider about all medications they are taking. Additionally, interactions with other intravenous solutions or supplements should be considered to avoid potential complications.

Frequently Asked Questions

20% PROSOL 0.98 G is used to provide essential amino acids to patients who cannot meet their nutritional needs through oral intake.

20% PROSOL 0.98 G is administered intravenously, meaning it is delivered directly into the bloodstream through a vein.

The common effects include improved nutritional status and overall well-being, as it supports various bodily functions.

Yes, it should be administered under medical supervision, and patients should be monitored for any adverse reactions.

Yes, threonine can interact with certain medications, so patients should inform their healthcare provider about all medications they are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.